154129-30-3 Usage
Uses
Used in Pharmaceutical Synthesis:
2-Iodo-5-methylpyrimidine is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to participate in a range of chemical reactions, facilitating the creation of diverse medicinal compounds.
Used in Organic Chemistry Research:
In the field of organic chemistry, 2-Iodo-5-methylpyrimidine serves as a valuable research tool. Its reactivity and structural features make it suitable for exploring new reaction pathways and developing innovative synthetic methods.
Used in Chemical Industry:
2-Iodo-5-methylpyrimidine is employed as a versatile building block in the chemical industry. Its ability to undergo multiple types of chemical transformations contributes to the production of a wide array of organic compounds, enhancing the capabilities of chemical manufacturing processes.
Each application underscores the compound's importance in different sectors, highlighting its adaptability and the breadth of its impact on modern chemistry and pharmaceutical development.
Check Digit Verification of cas no
The CAS Registry Mumber 154129-30-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,1,2 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 154129-30:
(8*1)+(7*5)+(6*4)+(5*1)+(4*2)+(3*9)+(2*3)+(1*0)=113
113 % 10 = 3
So 154129-30-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H5IN2/c1-4-2-7-5(6)8-3-4/h2-3H,1H3
154129-30-3Relevant academic research and scientific papers
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
-
Paragraph 0937, (2020/10/09)
The invention relates to modulators of Embryonic Ectoderm Development (EED) and/or Polycomb Repressive Complex 2 (PRC2) useful in the treatment of disorders and diseases associated with EEC and PRC2, being macrocyclic azolopyridine derivatives and compositions thereof of Formula (I), or a pharmaceutically acceptable salt, prodrug, solvate, hydrate, enantiomer, isomer, or tautomer thereof, wherein X1, X2, X3, A1, A2, Y, R1, R2, R3, and R4 are as described herein.
AMINO-HETEROCYCLIC COMPOUNDS
-
Page/Page column 33, (2010/08/07)
The invention provides PDE9-inhibiting compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, A, and n are as defined herein. Pharmaceutical compositions containing the compounds of Formula I, and uses thereof in treating neurodegenerative and cognitive disorders, such as Alzheimer's disease and schizophrenia, are also provided.
